EDN1 and endothelial dysfunction: Finally, the neuropeptide theory indicates that the release of potent vasoconstrictors, such as endothelin-1 and thromboxane A2, can lead to severe cerebral vasoconstriction, followed by endothelial dysfunction and hypoperfusion.